Table 6Survival and local control outcomes for local nonsurgical interventions in medically operable patients with stage I NSCLC

InterventionReported Overall Survival Rates, Number of Studies (Number of Patients)aReported Cancer-Specific Survival Rates, Number of Studies (Number of Patients)aReported Local Control Rates, Number of Studies (Number of Patients)a
PBRT3-years: 80%
1 study47
(n=28)
NRNR
SBRT3-years: 74%–91%
4 studies48,49,81,82
(n=291)

5-years: 70%, 70%
2 studies 49,83
(n= 87)
3-years: 91%
1 study48
(n=14)

5-years: 76%
1 study83
(n=87)
3-years: 93%
1study82
(n=177)

5-years: 87%
1 study83
(n= 87)

NR = not reported; NSCLC = non–small-cell lung cancer; PBRT = proton beam radiotherapy; SBRT = stereotactic body radiotherapy

a

Number of patients who were operable but refused surgery.

From: Results

Cover of Local Nonsurgical Therapies for Stage I and Symptomatic Obstructive Non–Small-Cell Lung Cancer
Local Nonsurgical Therapies for Stage I and Symptomatic Obstructive Non–Small-Cell Lung Cancer [Internet].
Comparative Effectiveness Reviews, No. 112.
Ratko TA, Vats V, Brock J, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.